DNA in the 13F filings

Ginkgo Bioworks Holdings Inc · CUSIP 37611X209

Sector · Pharmaceuticals and biotechnology Theme · Biological products Theme · Healthcare: biopharma and medtech· L3VLUP-defined

Quarter

Q3 2026 · early filers Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Quarter end: 31 Dec 2025; the date the book describes
Filed: 19 Feb 2026; latest of these filings; the earliest 22 Jan 2026
Managers listing it: 27; at least, of 95 tracked, among listed positions
Comparable managers: 92; filed both Q3 2025 and Q4 2025; 5 listed it in both
Shares listed: 8,018,727; combined, among listed positions
Reported value: $67m; combined, at the quarter end

Among the 92 comparable managers: 16 buyers (opened or added shares) and 7 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -389,476.

Managers listing DNA in Q4 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

ActionShare of book at least

27 of 27 holders

				Action		Filing
Viking Global Investors LP	3,577,128	$30m	0.08%	Held	0	17 Feb 2026 (the filing on sec.gov)
Baillie Gifford & Co	2,391,649	$20m	under 0.1%	Trimmed	-843,605	23 Jan 2026 (the filing on sec.gov)
Invesco Ltd	261,706	$2.2m	under 0.1%	Added	+50,565	19 Feb 2026 (the filing on sec.gov)
Squarepoint Ops LLC	196,820	$1.6m	under 0.1%	New	new	13 Feb 2026 (the filing on sec.gov)
Tudor Investment Corp	193,962	$1.6m	under 0.1%	New	new	17 Feb 2026 (the filing on sec.gov)
Jane Street Group LLC	181,755	$1.5m	under 0.1%	Added	+96,736	12 Feb 2026 (the filing on sec.gov)
Caxton Associates LLP	172,580	$1.4m	under 0.1%	Added	+42,992	13 Feb 2026 (the filing on sec.gov)
AQR Capital Management LLC	170,555	$1.4m	under 0.1%	Added	+19,860	17 Feb 2026 (the filing on sec.gov)
Glenview Capital Management LLC	149,379	$1.2m	under 0.1%	Held	0	17 Feb 2026 (the filing on sec.gov)
Susquehanna International Group LLP	100,996	$839k	under 0.1%	Trimmed	-136,062	17 Feb 2026 (the filing on sec.gov)
Verition Fund Management LLC	95,989	$798k	under 0.1%	Trimmed	-430	13 Feb 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc	94,873	$789k	under 0.1%	Added	+1,869	17 Feb 2026 (the filing on sec.gov)
Point72 Asset Management LP	76,908	$639k	under 0.1%	New	new	17 Feb 2026 (the filing on sec.gov)
Two Sigma Investments LP	60,360	$502k	under 0.1%	Trimmed	-114,303	17 Feb 2026 (the filing on sec.gov)
MFS Investment Management	50,273	$418k	under 0.1%	Added	+20,005	22 Jan 2026 (the filing on sec.gov)
Millennium Management LLC	48,901	$406k	under 0.1%	Added	+26,037	17 Feb 2026 (the filing on sec.gov)
Balyasny Asset Management LLC	37,977	$316k	under 0.1%	Trimmed	-59,941	17 Feb 2026 (the filing on sec.gov)
Acadian Asset Management LLC	34,699	$285k	under 0.1%	Added	+28,172	10 Feb 2026 (the filing on sec.gov)
D. E. Shaw & Co.	33,772	$281k	under 0.1%	New	new	17 Feb 2026 (the filing on sec.gov)
AllianceBernstein LP	23,092	$192k	under 0.1%	Held	0	17 Feb 2026 (the filing on sec.gov)
PDT Partners LLC	16,168	$134k	under 0.1%	Trimmed	-23,632	17 Feb 2026 (the filing on sec.gov)
Janus Henderson Group Ltd	14,534	$120k	under 0.1%	Held	0	17 Feb 2026 (the filing on sec.gov)
Two Sigma Advisers LP	11,856	$99k	under 0.1%	Trimmed	-19,252	17 Feb 2026 (the filing on sec.gov)
Brevan Howard Capital Management LP	11,401	$95k	under 0.1%	New	new	17 Feb 2026 (the filing on sec.gov)
Walleye Capital LLC	5,079	$42k	under 0.1%	New	new	13 Feb 2026 (the filing on sec.gov)

Page 1 of 2

Largest increases and reductions, by shares

Q3 2025 to Q4 2025, among managers that listed it in both quarters or opened it.

Increases

Squarepoint Ops LLCnew position · 196,820 shares now+196,820
Tudor Investment Corpnew position · 193,962 shares now+193,962
Jane Street Group LLCexisting position · 181,755 shares now+96,736
Point72 Asset Management LPnew position · 76,908 shares now+76,908
Invesco Ltdexisting position · 261,706 shares now+50,565

Reductions

Baillie Gifford & Coexisting position · 2,391,649 shares now-843,605
Susquehanna International Group LLPexisting position · 100,996 shares now-136,062
Two Sigma Investments LPexisting position · 60,360 shares now-114,303
Balyasny Asset Management LLCexisting position · 37,977 shares now-59,941
PDT Partners LLCexisting position · 16,168 shares now-23,632

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (7)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.

5 in Q3 2024 to 3 in Q2 2026

Tracked managers listing it, at least.

the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

DNA and GILD →DNA and AMGN →DNA and ARGX →Choose a stock to compare with DNA →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own DNA, latest filings →Back to the 13F Explorer →

Provided for information purposes only, not financial advice. The holdings shown here and anything drawn from them are illustrative, produced from assumptions you control, and must not be relied on for any investment, financial or business decision. Read the full notice

Not advice, and not a recommendation. Everything L3VLUP publishes is provided for information purposes only. Nothing here is financial, investment, legal, tax or accounting advice, a personal recommendation, or an offer or solicitation to buy or sell any security or financial instrument. It takes no account of anyone’s objectives, financial situation or needs.

Not a regulated adviser. L3VLUP does not provide regulated financial services. Speak to a suitably qualified and regulated professional before acting on anything you read here.

Illustrative figures. Default values are plausible starting points chosen so a model has somewhere to begin. They are not data, not a view on any company, and not calibrated to anything. Outputs move with whatever you type in.

Third-party data. Where live figures appear they come from third parties, including public filings and market feeds. They may be delayed, incomplete, restated, mis-tagged at source or simply wrong, and their providers do not endorse or verify this page. Every figure links to where it came from. Check it there before relying on it. Past performance is not a guide to future performance.

Company names and logos. Names, tickers and logos are the trademarks of their owners and appear only to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, none of them took part in preparing the exercise, and nothing here is a statement by or about any of them. See third-party names and marks.

No warranty, and limited liability. This page is provided “as is” without warranty of any kind. To the fullest extent permitted by law, L3VLUP accepts no liability for any loss or damage arising from use of, or reliance on, anything on it. Nothing in this notice limits any liability that cannot lawfully be limited.

Full terms: Information Purposes and No Advice · Terms

Quarter	Holders	Reported value	Buyers	Sellers
Q3 2024	5	$62m	5	0
Q4 2024	4	$72m	1	3
Q1 2025	4	$43m	1	1
Q2 2025	4	$80m	0	3
Q3 2025	5	$104m	1	2
Q4 2025	4	$52m	16	7
Q1 2026	2	$37m	9	16
Q2 2026	3	$61m	11	10